Urology Associates of Central California

Fresno, California 93720

3 studies enrolling now · 15 studies all time

What they study most

Benign Prostatic Hyperplasia (BPH), Bladder Cancer, Cystitis, Interstitial, Hematuria - Cause Not Known, Intermediate Risk Non-Muscle Invasive Bladder Cancer, Metastatic Castrate-sensitive Prostate Cancer, Prostate Cancer, Prostate Cancer (Adenocarcinoma), Prostatic Neoplasms, Urge Incontinence

Studies at this site

• Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer — Recruiting now
• Post-Market Study to Assess iTind Safety in Comparison to UroLift — Recruiting now
• Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine. — Recruiting now
• A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPC — Running, not enrolling
• A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX — Completed
• ADSTILADRIN Early Utilization and Outcomes in the Real World Setting — Stopped early
• Effectiveness of eCoin at Sensory and Subsensory Amplitudes — Completed
• Registry to Evaluate Long-Term Outcomes in Patients Who Undergo 68-Ga-PSMA-11 PET/CT Imaging Evaluations — Stopped early
• A Study To Investigate Tanezumab In Patients With Interstitial Cystitis/ Painful Bladder Syndrome — Stopped early
• An Effectiveness and Safety Study of PF-04383119 for the Treatment of Pain in Interstitial Cystitis — Completed
• A Registry for Hereditary Cancer Risk Assessment and Genetic Testing — Completed
• PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy — Completed
• A Study of Degarelix in Patients With Prostate Cancer — Completed
• R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence — Status unconfirmed
• Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer — Completed